Cepheid Recalls MRSA Blood Culture Test for Second Time; Company, Analysts Unconcerned
January 12, 2012
Cepheid Recalls MRSA Blood Culture Test for Second Time; Company, Analysts Unconcerned
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- More Trouble for Cepheid MRSA Test as Abaxis Sues for Patent Infringement
July 15, 2010 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Q&A: UK Hospitals Find Cepheid's Xpert MRSA Test at Point of Care Can Shave Hours Off Time-to-Result
December 10, 2009 / PCR Insider - Cepheid's Q1 Revenues Grow on Strong Clinical Reagent Sales; Analysts 'Unconcerned' with Net Loss
April 26, 2012 / PCR Insider - Roche, Cepheid Execs Wrangle over Clinical Market for PCR-based MRSA Tests
July 29, 2010 / PCR Insider